TY - JOUR T1 - Conjunctival polymerase chain reaction-tests of 2019 novel coronavirus in patients in Shenyang, China JF - medRxiv DO - 10.1101/2020.02.23.20024935 SP - 2020.02.23.20024935 AU - Li Xu AU - Xinyue Zhang AU - Wei Song AU - Baijun Sun AU - Jinping Mu AU - Bing Wang AU - Zhiqian Wang AU - Yehong Cao AU - Xue Dong Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/02/25/2020.02.23.20024935.abstract N2 - Purpose The 2019 novel coronavirus(COVID-19) mainly transmitted by person-to-person through inhalation of respiratory droplets. We report the laboratory results of conjunctival PCR-tests and some clinical features of these patients in shenyang China.Design This is a cross-sectional non-randomized studySubjects The study include 14 confirmly diagnosed cases, 16 suspected cases and some medical observed patients.Methods All patients with diagnosed and suspected COVID-19 were admitted to a designated hospital in Shenyang, China. We collected conjunctival samples of these patients to do the laboratory tests by real time RT-PCR. Medical observed patients were enrolled if they had clinical symptoms. Then we analysed the PCR results and clinical data from eletronic medical records in order to find some relationships.Main Outcome Measures Clinical condition and PCR results. of conjunctival swabs compared with other specimensResults One of the identified case coverted from suspected case without typical clinical symptoms. Twenty-two medical observed cases were removed because none of them converted to identified cases. One of the suspected converted to identified case recently. The included cases in our study are imported cases with less underlying diseases and the severity of their infection was relatively moderate. All the conjunctival results of PCR-test were negative. Two cases had typical clinical symptoms but were finally confirmed by repeated pharynxswabtests.Conclusion Conjunctiva may be a transmission way of COVID-19. And ocular conjunctival swabs in combination with PCR test could be a non-invasive, convenient and feasible diagnostic method for identifying the infection of COVID-19. Emphasis on the false-negative results is vital.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMinistry of Shenyang science and technologyAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe data are all in the manuscriptRT-PCRreverse transcription polymerase chain reactionCOVID-19coronavirus disease 2019 ER -